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ABSTRACT
Objective To assess life expectancy in relation to
cardiovascular risk factors recorded in middle age.
Design Prospective cohort study.
Setting Men employed in the civil service in London,
England.
Participants 18863 men examined at entry in 1967-70
andfollowedfor38years,ofwhom13501diedand4811
were re-examined in 1997.
Main outcome measures Life expectancy estimated in
relation to fifths and dichotomous categories of risk
factors (smoking, “low” or “high” blood pressure
(≥140 mm Hg), and “low” or “high” cholesterol (≥5 mmol/
l)), and a risk score from these risk factors.
Results At entry, 42% of the men were current smokers,
39% had high blood pressure, and 51% had high
cholesterol.Atthere-examination,abouttwothirdsofthe
previously “current” smokers had quit smoking shortly
afterentryandthemeandifferencesinlevelsofthosewith
high and low levels of blood pressure and cholesterol
were attenuated by two thirds. Compared with men
withoutanybaselineriskfactors,thepresenceofallthree
risk factors at entry was associated with a 10 year shorter
lifeexpectancyfromage50(23.7v33.3years).Compared
with men in the lowest 5% of a risk score based on
smoking, diabetes, employment grade, and continuous
levels of blood pressure, cholesterol concentration, and
body mass index (BMI), men in the highest 5% had a
15 year shorter life expectancy from age 50 (20.2 v 35.
4 years).
Conclusion Despite substantial changes in these risk
factorsovertime,baselinedifferencesinriskfactorswere
associatedwith10to15yearshorterlifeexpectancyfrom
age 50.
INTRODUCTION
Mortality rates from cardiovascular diseases in the
United Kingdom have declined steadily since their
peak levels in the early 1970s,
12 as have mortality
rates from non-vascular causes, resultingin substantial
improvements in life expectancy. These improve-
ments are mainly attributable to population-wide
changes in the three main cardiovascular risk factors
(cigarette smoking, raised cholesterol concentration,
and high blood pressure) and to better treatment of
individuals with pre-existing vascular disease.
3-5 The
Whitehall study of 19019 male civil servants in Lon-
don—who were aged 40-69 when first examined in
1967-70—wassetupatthepeakofthevasculardisease
epidemic in the UK to assess the importance of risk
factors for prediction of coronary and vascular
mortality.
67 The initial results were used by the late
Geoffrey Rose to assess “high risk” and “population”
approaches that have guided public health strategies
for the prevention of cardiovascular disease.
8
After nearly 40 years of follow-up for cause specific
mortality, the Whitehall study provides a rare oppor-
tunity to estimate the impact of differences in cardio-
vascular risk factors measured during middle age on
lifeexpectancy.We hadthreeaims: tocomparetrends
invascularandnon-vascularmortalityintheWhitehall
study with those in the UK population as a whole; to
estimate life expectancy from age 50 in UK men in
relation to single baseline measurements of the three
main vascular risk factors (smoking, blood pressure,
and cholesterol concentration), alone and in combina-
tion; and to estimate life expectancy in relation to a
more accurate characterisation of cardiovascular risk
factors,including,inadditiontothethreemaincardio-
vascularriskfactors,diabetes,bodymassindex(BMI),
and employment grade.
METHODS
UK mortality trends
AnnualcausespecificUK mortalityratesfrom1950to
2005 were obtained from the World Health Organiza-
tion and standardised for the mean of the component
five year age groups for deaths occurring at age 35-69
(middle age)and 70-79 (old age)(www.mortalityfroms
moking.com). The age standardised mortality rates
were estimated separately for vascular and non-vascu-
lar causes for men and women in these age groups.
Whitehall study population
Data were collected from 19019 men aged 40-69 who
were working in the civil service in Londonwhen they
werefirstexaminedbetweenSeptember1967andJan-
uary 1970.
67 Participation in the study involved the
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tion to record height, weight, and blood pressure; to
undergo electrocardiography and lung function tests;
andtohaveabloodsamplecollectedformeasurement
of blood total cholesterol and glucose concentrations.
The questionnaire included questions about symp-
toms, medical history, smoking habits, civil service
employment grade, and marital status. Employment
grades were categorised into threegroups: administra-
tive, professional, or executive; clerical; and other
unskilled manual jobs. The employment grade of the
886 men who worked in the Diplomatic Service and
British Council was not comparable with the rest of
the study participants, and hence these men were
excluded from any analyses of employment grade.
At study entry, a trained study nurse measured
blood pressure once in the left arm with the London
School of Hygiene sphygmomanometer. The nurse
recordedsystolicbloodpressureatthefirstappearance
ofthearterialflowsounds.Height(inshoes)andweight
were measured and BMI (kg/m
2) calculated. Blood
samples were collected from the ear lobe into 2 mm
glass tubing. Blood total cholesterol concentration
was measured with a Technicon method and blood
glucose was measured by a ferricyanide reduction
method. All participants (except those with self
reported diabetes) had blood glucose measured two
hours after drinking a dextrose drink. Those with a
glucose concentration of 11.1 mmol/l or greater were
classified as having newly diagnosed diabetes, and
those with concentrations of 5.3-11.0 mmol/l were
classified as having glucose intolerance.
Ascertainment of cause specific mortality
Using the procedures of the Office for National Statis-
tics, we traced and flagged the records of 18863 men
(99.2%of cohort members)and identifieddeathsup to
30 September 2005. Among the 13501 who died,
11317 (83.8%) deaths were coded according to ICD-
8 (international classification of diseases, eighth revi-
sion), 831 (6.2%) according to ICD-9, and 1353
(10.0%) according to ICD-10. Deaths from cancer
were classified into groups that have previously been
shown
9 to be probably related to cigarette smoking
(lung,stomach,pancreas,bladder,upperaerodigestive
(including oesophagus), kidney, myeloid leukaemia,
and liver) and a group for which this was regarded as
unlikely. Only 43 deaths were of unknown cause, and
these deaths contributed to analyses of total mortality
but not to cause specific mortality.
Re-examination of surviving participants in old age
After the success of a pilot study of the feasibility of
contacting surviving participants in 1995, all 8448 sur-
viving participants were invited to participate in
another survey in 1997-8.
10 A postal questionnaire
asked for details of any diagnoses of heart attack,
angina, or stroke, medications taken in the past
month, smoking status, and last known civil service
employment grade.
11 The 7044 participants who
responded (83%) were subsequently sent a blood
collection kit and asked to attend their local surgery
to have a blood sample collected and for blood pres-
sure, height, and weight to be recorded. Non-fasting
blood samples were obtained from 5434 men (77% of
respondents), from which blood lipids were success-
fully measured for 5355 (98.5%).
12 We had complete
data on blood pressure, blood cholesterol concentra-
tion, and BMI from both the initial and later survey
for 4811 men.
Statistical analysis
We estimated cause specific death rates overall and
separately by age at risk (50-59, 60-69, 70-79, and
≥80) and calendar period (1967-79, 1980-9, 1990-9,
and 2000-5). Follow-up before the age of 50 contribu-
ted only79 deaths,andwe excludedthesedeathsfrom
all analyses. We estimated associations of age at risk
and calendar period with mortality using Cox propor-
tional hazards regression to estimate the hazard ratios
associated with a 10 year increase in each of these
exposures.
Coxregressionwasusedtoestimatetherelevanceof
various baseline risk factors (blood pressure, choles-
terol concentration, and BMI (by fifths of their distri-
butions), smoking (never, ex-smoker, pipe/cigar only,
current), employment grade, marital status, and
glucose intolerance/diabetes (defined as self reported
diabetes,newlydiagnoseddiabetes,orglucoseintoler-
ance) to vascular and non-vascular mortality, after
adjustment for age at risk and calendar period. The
few men with data missing for these characteristics
were excluded from these, but not other, calculations.
All cause mortality rates for each five year age at risk
groupwerecalculatedforeachlevelofeachriskfactor.
Byusingstandardlifetablemethods,theseagespecific
mortality rates were used to estimate life expectancy
from age 50 (defined as the number of years one is
expectedtolivehavingsurvivedtoage50)anditsstan-
dard error.
Wedichotomisedthethreemaincardiovascularrisk
factors: current smoker (yes/no); baseline blood pres-
sure (“high” (systolic blood pressure ≥140 mm Hg) or
“low”) and baseline cholesterol concentration (“high”
(≥5.0 mmol/l)or “low”). Wethen separatelyestimated
vascular and non-vascular mortality and life expec-
tancy from age 50 in each of the eight different combi-
nations of these risk factors. Subsequently, we
estimated mortality and life expectancy in relation to
an all cause mortality risk score using the three main
risk factors (with blood pressure and cholesterol con-
centrationnowconsideredascontinuousvariablesand
smoking categorised into four groups) and the three
mainriskfactorswithBMI(usingbothlinearandquad-
ratic terms
13), diabetes, and employment grade. The
two risk scores were calculated for each individual
with no missing values by using the coefficients
obtained from Cox proportional hazard models of all
causemortalitywiththeabovevariables.Hazardratios
and life expectancy were estimated by fifths of the dis-
tribution of risk score and, for the full risk model only,
for the highest 5% compared with the lowest 5% of the
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isation of these risk factors).
Finally, to assess the extent of variation within an
individual in risk factors between middle and old age,
weestimatedthemeanlevelsofriskfactorsrecordedat
the survey in 1997 for risk categories defined in 1970.
Specifically,wecomparedthedifferences(d1)between
the mean blood pressure, cholesterol concentration,
and BMI of those classified as “high” or “low” values
at entry with the corresponding differences at the sec-
ond survey (d2) (the ratio d2/d1 is then the regression
dilution ratio over about a 28 year period). We
repeated these analyses after excluding men who, at
re-survey,reportedahistoryofcardiovasculardisease,
diabetes mellitus, or cancer or use of medication to
lower cholesterol concentration or blood pressure.
All statistical analyses were conducted with SAS com-
puter software.
RESULTS
Trends in vascular and non-vascular mortality rates in UK
population
ThefigureshowstheagestandardisedannualUKmor-
tality rates for vascular and non-vascular causes of
death at ages 35-69 between 1950 and 2005. Through-
out this period, vascular mortality rates in middle age
in men were about twice those in women, peaking in
1970anddeclininglinearlybyabout2%ayearinboth
sexes (or by almost 70% between 1970 and 2005). The
proportion of deaths attributed to vascular disease in
middleagealsodeclinedbetween1970and2005,from
about 50% to 30% in men and from 40% to 20% in
women. The figure also shows age standardised mor-
tality rates from vascular and non-vascular causes for
men and women aged 70-79. For both sexes, the abso-
lute mortality rates in old age were about fivefold
greater than those in middle age. In old age, vascular
mortality rates declined by about two thirds between
1950 and 2005 in both men and women, but non-vas-
cularmortalityratesdeclinedtoamuchlesserextentin
this age group. The proportion of deaths attributed to
vasculardiseaseinoldagedeclinedfromabout60%in
1950 to less than 40% in 2005 for both men and
women.
Trends in cause specific mortality rates in the Whitehall
study
Table 1showstheagespecificdeathratesandnumber
of deaths from specific causes for men in each decade
of age at risk. About a quarter of all deaths occurred
before the age of 70. The median age at death was 76,
andthemediantimetodeath22years.Theproportion
of deaths from vascular causes declined with age, ran-
gingfrom54%amongthoseintheir50sto45%among
those aged ≥80. The overall mortality rate increased
threefold for every 10 year increase in age (hazard
ratio per 10 years older 2.95, 95% confidence interval
2.87to3.07),butmortalityratesforstrokeandrespira-
tory disease increased over fourfold for every 10 year
increase in age.
Table 2 shows the distribution of deaths by calen-
dar period over the 38 year follow-up and the age
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10 year increase in calendar period. The secular
reductions in vascular and non-vascular mortality
rates observed in the Whitehall study were similar to
those observed for the UKpopulationas a whole (fig-
ure). After adjustment for age at risk, the decline in
vascular mortality rates was more than twice that for
non-vascular causes (hazard ratio per 10 year
calendar period: 0.75 (0.73 to 0.79) for vascular
causes and 0.89 (0.86 to 0.93) for non-vascular
causes). The age adjusted mortality rates for cancers
probably related to smoking declined by about 23%
per 10 years, whereas those believed to be unrelated
to smoking were unaltered (0.77 (0.72 to 0.82) v 1.03
(0.96 to1.11), respectively), illustrating the impor-
tance of cessation of smoking in this population.
Table 1 |Cause specific mortality* by age (years) at death. Figures are rates (number of deaths)
Cause of death 50-59 60-69 70-79 ≥80 All ages HR† per 10 years (95% CI)
Vascular disease:
Coronary heart disease 2.9 (338) 6.4 (1012) 12.5 (1556) 23.9 (1126) 9.0 (4032) 2.61 (2.49 to 2.74)
Stroke 0.3 (35) 1.0 (151) 3.6 (453) 12.4 (583) 2.7 (1222) 4.11 (3.76 to 4.50)
Other vascular 0.4 (50) 1.2 (190) 3.6 (444) 9.8 (462) 2.6 (1146) 3.34 (3.05 to 3.65)
All vascular 3.6 (423) 8.5 (1353) 19.7 (2453) 46.1 (2171) 14.3 (6400) 2.96 (2.85 to 3.08)
Cancers:
Lung cancer 0.6 (74) 1.8 (279) 3.2 (393) 3.9 (185) 2.1 (931) 2.55 (2.31 to 2.81)
Colorectal cancer 0.3 (32) 0.7 (110) 1.5 (189) 2.5 (118) 1.0 (449) 2.10 (1.82 to 2.43)
Bladder cancer 0.1 (6) 0.2 (31) 0.6 (78) 1.3 (63) 0.4 (178) 3.35 (2.66 to 4.21)
Prostate cancer 0.0 (2) 0.4 (63) 1.9 (241) 5.1 (240) 1.2 (546) 3.31 (2.90 to 3.78)
Other cancers 1.1 (129) 2.5 (395) 4.9 (612) 9.2 (432) 3.5 (1568) 1.94 (1.79 to 2.09)
Cancers related to smoking 1.2 (146) 3.2 (512) 6.4 (799) 9.6 (453) 4.3 (1910) 2.35 (2.19 to 2.51)
Cancers not related to smoking 0.8 (97) 2.3 (366) 5.7 (714) 12.4 (585) 3.9 (1762) 2.31 (2.15 to 2.48)
All cancer 2.1 (243) 5.5 (878) 12.2 (1513) 22.0 (1038) 8.2 (3672) 2.33 (2.22 to 2.45)
Respiratory 0.3 (41) 1.1 (182) 5.0 (627) 19.4 (916) 3.9 (1766) 4.57 (4.24 to 4.93)
Injuries and suicides 0.2 (29) 0.4 (58) 0.5 (60) 1.0 (48) 0.4 (195) 1.81 (1.46 to 2.25)
Other causes 0.4 (44) 1.1 (170) 3.6 (454) 14.4 (678) 3.0 (1346) 3.56 (3.27 to 3.88)
All non-vascular causes 3.0 (357) 8.1 (1288) 21.3 (2654) 56.9 (2680) 15.6 (6979) 2.92 (2.85 to 3.06)
Unknown cause 0.1 (8) 0.1 (8) 0.1 (18) 0.2 (9) 0.1 (43) —
All causes‡ 6.6 (788) 16.7 (2649) 41.1 (5125) 103.0 (4860) 29.9 (13422) 2.95 (2.87 to 3.07)
*Mortality rates per 1000 person years.
†Hazard ratios associated with increase in 10 years of age adjusted for calendar period.
‡Includes 43 deaths where specific cause was unknown.
Table 2 |Cause specific mortality by calendar period of follow-up. Figures are deaths; hazard ratios adjusted for age at risk (95% confidence intervals)
Cause of death 1967-9* 1980-9 1990-9 2000-5 All periods†
Vascular disease:
Coronary heart disease 914 1243; 0.71 (0.64 to 0.78) 1316; 0.52 (0.46 to 0.58) 559; 0.38 (0.32 to 0.43) 4032; 0.72 (0.69 to 0.76)
Stroke 121 312; 0.90 (0.71 to 1.15) 471; 0.66 (0.51 to 0.85) 318; 0.61 (0.46 to 0.81) 1222; 0.83 (0.77 to 0.91)
Other vascular 148 328; 0.93 (0.75 to 1.16) 432; 0.69 (0.54 to 0.89) 238; 0.58 (0.44 to 0.77) 1146; 0.81 (0.75 to 0.89)
All vascular 1183 1883; 0.76 (0.70 to 0.83) 2219; 0.56 (0.51 to 0.61) 1115; 0.44 (0.39 to 0.50) 6400; 0.75 (0.73 to 0.79)
Cancers:
Lung 255 323; 0.61 (0.51 to 0.73) 264; 0.37 (0.30 to 0.46) 89; 0.25 (0.18 to 0.34) 931; 0.62 (0.56 to 0.68)
Colorectal 80 139; 0.99 (0.73 to 1.36) 155; 0.87 (0.61 to 1.24) 75; 0.86 (0.56 to 1.32) 449; 0.94 (0.82 to 1.08)
Bladder 24 53; 0.80 (0.47 to 1.38) 68; 0.59 (0.32 to 1.07) 33; 0.45 (0.23 to 0.91) 178; 0.76 (0.61 to 0.94)
Prostate 28 136; 1.54 (1.00 to 2.38) 248; 1.57 (1.00 to 2.45) 134; 1.41 (0.87 to 2.28) 546; 1.03 (0.90 to 1.16)
Other cancers 277 438; 1.02 (0.86 to 1.21) 593; 1.19 (0.98 to 1.44) 260; 1.06 (0.84 to 1.33) 1568; 1.04 (0.96 to 1.12)
Cancers related to smoking 433 608; 0.73 (0.63 to 0.84) 620; 0.57 (0.48 to 0.67) 249; 0.45 (0.36 to 0.55) 1910; 0.77 (0.72 to 0.82)
Cancers not related to smoking 231 481; 1.16 (0.97 to 1.39) 708; 1.26 (1.04 to 1.53) 342; 1.14 (0.91 to 1.43) 1762; 1.03 (0.96 to 1.11)
All cancer 664 1089; 0.87 (0.78 to 0.97) 1328; 0.80 (0.70 to 0.90) 591; 0.68 (0.58 to 0.79) 3672; 0.88 (0.84 to 0.93)
Respiratory 151 391; 0.83 (0.67 to 1.03) 769; 0.73 (0.58 to 0.91) 455; 0.56 (0.44 to 0.71) 1766; 0.82 (0.76 to 0.88)
Injuries and suicides 52 59; 0.94 (0.61 to 1.44) 53; 0.78 (0.46 to 1.35) 31; 0.78 (0.40 to 1.53) 195; 0.91 (0.73 to 1.14)
Other causes 122 263; 0.95 (0.74 to 1.22) 573; 1.12 (0.86 to 1.45) 388; 1.07 (0.80 to 1.42) 1346; 1.04 (0.95 to 1.12)
Non-vascular 989 1802; 0.88 (0.80 to 0.96) 2723; 0.83 (0.75 to 0.91) 1465; 0.70 (0.63 to 0.79) 6979; 0.89 (0.86 to 0.93)
All causes‡ 2181 3699; 0.82 (0.77 to 0.87) 4962; 0.68 (0.64 to 0.73) 2580; 0.56 (0.52 to 0.61) 13 422; 0.83 (0.81 to 0.85)
*Reference category (that is, hazard ratio=1.0).
†Hazard ratios associated with an increase in calendar period of 10 years adjusted for age.
‡Includes 43 deaths where specific cause was unknown.
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middle and old age
Among the 7044 men who completed the question-
naire in 1997, 13% were current smokers (compared
with40%ofallmenin1967-70)and58%wereex-smo-
kers. Of the ex-smokers, the mean age at quitting
smoking was 52, an average of 26 years earlier (that
is, shortly after entry into the study). In addition, of
the men who had been cigarette smokers in 1967-70,
just 29% were still current smokers at re-survey (indi-
cating that over two thirds had quit, for some reason,
during that time). Mean blood pressure, cholesterol
concentration, and BMI were obtained for 4811 men
atre-survey,ofwhom1930hadnohistoryofdiseaseor
medicationtolowerbloodpressureorcholesterolcon-
centration. The difference between mean levels of sys-
tolic blood pressure for men with “high” versus “low”
blood pressure at baseline declined by over two thirds
(30.6 v 8.3 mm Hg) between 1967-70 and 1997 in all
men with available data (see table A on bmj.com).
Similarly, the difference in mean levels between
“high” and “low” cholesterol declined by over two
thirds (1.86 v 0.49 mmol/l) over this period in all men
(see table Aon bmj.com).Differencesin BMIbetween
the obeseand non-obese groups, however,declined to
a lesser extent (9.9 v 5.6) over this period. Exclusion of
men with previous disease or use of medication to
lower blood pressure or cholesterol concentration did
notmateriallyalter the extentoftheobservedvariabil-
ity within individuals.
Cardiovascular risk factors and life expectancy
Table 3 shows the prevalence of the major cardio-
vascular risk factors at entry and their relation with
vascular and non-vascular mortality and life expec-
tancy. In 1967-70, 7919 men (42%) reported that they
were current cigarette smokers and 3502 (18%)
reported that they had never smoked tobacco. After
adjustment for age and calendar period, the hazard
ratios associated with current smoking compared
with never smoking were 1.57 (1.46 to 1.69) for vascu-
lar mortality and 2.07 (1.92 to 2.22) for non-vascular
mortality. Current smoking defined at study entry was
associated with an average 6.3 year difference in life
expectancy at age 50 compared with non-smoking.
As the re-survey of survivors in 1997 indicated that
about two thirds of smokers quit smoking within a
fewyearsafterentryintothestudy,theobservedeffects
of current smoking for cause specific mortality have
probably been underestimated by about 50% (see
appendix on bmj.com).
Table 3 shows that the difference in life expectancy
between the highest and lowest fifths of systolic blood
pressure was 5.2 years. Even dichotomising blood
pressure crudely into two categories, “high” versus
“low” blood pressure (corresponding to a “usual” dif-
ference in systolic blood pressure of probably about
15 mm Hg (see table A on bmj.com) was associated
with a hazard ratio of 1.64 (1.56 to 72) for vascular
mortality,and1.09(1.04to1.14)fornon-vascularmor-
talityanda3.5yearshorterlifeexpectancy(seetableB
on bmj.com). “High” cholesterol (corresponding to a
“usual” difference in total cholesterol of probably
about 0.9 mmol/l; see table A on bmj.com) was asso-
ciated with a hazard ratio of 1.24 (1.18 to1.30) for vas-
cular mortality, and a one year shorter life expectancy
at age 50 (see table B on bmj.com). Table 3 shows that
difference in life expectancy between the highest and
lowest fifths of total cholesterol concentration was
1.9years.Differencesinupperandloweremployment
grades were associated with 5.4 year difference in life
expectancy. Married men had a 2.2 year longer life
expectancy than unmarried men (but this association
was entirely explained by differences in the other risk
factors). Glucose intolerance or diabetes mellitus at
baseline (prevalence 6.9%) was associated with a
3.6 year shorter life expectancy at age 50.
Associations of life expectancy with combinations of
cardiovascular risk factors
Table 4 shows the effects of combinations of the three
main risk factors for cause specific mortality and life
expectancy. The hazard ratios for vascular mortality
increased progressively with increasing number of
cardiovascular risk factors when compared with men
without any of them. Compared with the 17% of men
without any baseline risk factors, men with all three
risk factors (8.3%) in 1967-70 had a threefold higher
vascular mortality rate, a twofold higher non-vascular
mortality rate, and a 9.6 year shorter life expectancy
from age 50 (23.7 v 33.3 years).
Associations of life expectancy with mortality risk scores
Classification of men by fifths of a risk score based on
fourcategoriesofsmokingandcontinuousmeasuresof
bloodpressureandcholesterolconcentrationwasasso-
ciated with a 9.3 year difference in life expectancy at
age50(24.2v33.5years)betweenthehighestandlow-
estfifths(table 5).Additionalinclusionofglucoseintol-
erance, employment grade, and BMI was associated
with a 10.4 year difference in life expectancy at age
50 (23.6 v 34.0 years) between the highest and lowest
fifths, and a 15.2 year difference (20.2 v 35.4 years)
when the highest and lowest 5% of the distributions
were compared (table 5).
DISCUSSION
Despite the fact that during follow-up many men
stopped smoking, and there was also substantial varia-
tion in other risk factors, the presence of all three
cardiovascular risk factors (smoking, high blood pres-
sure,andhighcholesterolconcentration)measuredon
a single occasion in middle age (even when crudely
categorised) predicteda threefoldhigherrate ofvascu-
lar mortality, a twofold higher rate of non-vascular
mortality, and an almost 10 year shorter life expec-
tancy from age 50 compared with none of the risk fac-
tors. Categorisation of study participants by fifths of a
risk score involving the three main cardiovascular risk
factorstogetherwithglucoseintolerance,employment
grade, and BMI was associated with a 10.4 year differ-
ence in life expectancy between those in the top
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Moreextremeclassificationofmenintothehighest5%
andthelowest5%ofariskscorethatincludedallavail-
able risk factors was associated with a difference of
15.2 years in life expectancy from age 50.
Strengths and limitations
The present study has several strengths, including a
prospective design, large sample size, availability of
repeat measurements between middle and old age,
prolonged duration of follow-up, a large number of
deaths, and virtually complete mortality follow-up.
The “healthy worker” effect of studying an employed
cohort working in the civil service, however,
accounted for longer life expectancies than in the gen-
eralpopulation,butthiswould havehad little effecton
comparisons of risk factors within the population stu-
died. Furthermore, only men were enrolled in the
study and blood lipid data were available only for
totalcholesterolconcentration(ratherthancholesterol
fractions or apolipoproteins, which are much stronger
predictors of vascular mortality than total
cholesterol).
1214 The effects of these factors on mortal-
itymightalsohavebeenslightlyunderestimatedbythe
increased use of aspirin, statins, and blood pressure
lowering drugs during follow-up (in 1997, 29% of re-
survey participants were taking aspirin, 28% were tak-
ing blood pressure lowering drugs, but only 2% were
taking statins).
In the UK, life expectancy at birth for men has
increased from 69.3 in the early 1970s to 77.0 in
2005. In the Whitehall study, life expectancy at age
50 varied from 24.8 to 30.2 years between the lower
and upper employment grades, whereas life expec-
tancy at birth for UK men in the registrar general’s
classificationschemevariedfrom72.7ingradeVcate-
gory to 80 in grade I category.
1516 We found propor-
tional improvements in cardiovascular and non-
cardiovascular mortality comparable with those
observed for UK men over this period. The absolute
Table 3 |Hazard ratios for vascular and non-vascular mortality and life expectancy by risk factors at study entry when examined separately
Risk factors
Prevalence
at baseline (%)
Vascular deaths Non-vascular deaths Mean (SE) life expectancy
at age 50 Deaths HR* (95% CI) Deaths HR* (95% CI)
Smoking:
Never smoker 18.4 1019 1.0 965 1.0 32.6 (0.2)
Ex-smoker 36.5 2324 1.11 (1.03 to 1.20) 2436 1.26 (1.17 to 1.35) 30.8 (0.1)
Pipe/cigar only 3.5 222 1.15 (0.99 to 1.33) 221 1.24 (1.07 to 1.43) 30.9 (0.5)
Current smoker 41.7 2834 1.57 (1.46 to 1.69) 3352 2.07 (1.92 to 2.22) 26.3 (0.1)
Systolic blood pressure (fifth):
1 (lowest) 20.9 970 1.0 1509 1.0 31.1 (0.2)
2 20.2 1052 1.11 (1.02 to 1.21) 1394 0.95 (0.88 to 1.02) 30.8 (0.2)
3 20.3 1266 1.36 (1.25 to 1.48) 1421 0.99 (0.92 to 1.07) 29.8 (0.2)
4 18.0 1276 1.60 (1.48 to 1.74) 1240 1.02 (0.95 to 1.10) 28.5 (0.2)
5 (highest) 20.7 1835 2.17 (2.01 to 2.35) 1412 1.11 (1.03 to 1.19) 25.9 (0.2)
Cholesterol (fifth)
1 (lowest) 18.9 1008 1.0 1338 1.0 30.0 (0.2)
2 21.1 1218 1.11 (1.02 to 1.20) 1449 0.99 (0.92 to 1.07) 29.7 (0.2)
3 19.1 1135 1.13 (1.04 to 1.23) 1333 1.00 (0.93 to 1.08) 29.5 (0.2)
4 20.6 1309 1.20 (1.10 to 1.30) 1332 0.92 (0.85 to 0.99) 29.3 (0.2)
5 (highest) 20.3 1507 1.49 (1.38 to 1.62) 1226 0.92 (0.85 to 1.00) 28.1 (0.2)
BMI:
1 (lowest) 21.0 1124 1.0 1644 1.0 29.0 (0.2)
2 19.5 1134 0.99 (0.91 to 1.07) 1313 0.77 (0.72 to 0.83) 30.4 (0.2)
3 20.3 1294 1.08 (1.00 to 1.17) 1347 0.77 (0.71 to 0.82) 29.9 (0.2)
4 19.0 1296 1.15 (1.06 to 1.25) 1288 0.78 (0.73 to 0.84) 29.4 (0.2)
5 (highest) 20.3 1550 1.41 (1.30 to 1.52) 1386 0.87 (0.81 to 0.94) 27.7 (0.2)
Employment grade:
Administrative/professional/executive 73.4 4290 1.0 4526 1.0 30.2 (0.1)
Clerical 16.6 1143 1.26 (1.18 to 1.35) 1286 1.43 (1.34 to 1.52) 26.8 (0.2)
Other 10.0 709 1.31 (1.20 to 1.42) 883 1.69 (1.57 to 1.82) 24.8 (0.4)
Marital status:
Married 88.0 5633 1.0 6055 1.0 29.5 (0.1)
Other 12.0 764 1.15 (1.07 to 1.24) 923 1.31 (1.23 to 1.41) 27.3 (0.3)
Blood glucose:
Normoglycaemic 93.1 5810 1.0 6418 1.0 29.5 (0.1)
Glucose intolerant or diabetic 6.9 545 1.44 (1.31 to 1.57) 514 1.28 (1.17 to 1.40) 25.9 (0.3)
BMI=body mass index.
*Hazard ratios adjusted for age at risk and calendar period.
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ever, was greater than that observed for similar aged
men living in England and Wales at this period (prob-
ably because of the “healthy worker” effect).
Comparisons with other studies
Ourresultsconfirmthatabsolutecardiovasculardeath
rates increase exponentially up to the 10th decade of
life, similar to the pattern observed in the physicians’
health study in the United States over the same
period.
17 Moreover, our results showing the impor-
tance of smoking, cholesterol concentration, and
blood pressure on life expectancy are concordant
with those of the physicians’ health study (which also
found that smoking, hypertension, diabetes, and
obesity accounted for most of the differences in survi-
val to age 90
18). As the prevalence of smoking among
men in the UK declined steadily between 1970 and
2004 (from about 44% to 26%),
16 our study will have
underestimated the associations with persistent smok-
ing compared with never smoking. The British doc-
tors’ study recorded smoking habits each decade
over the age of 50
19 and found that current smokers
who continued to smoke died on average about
10 years younger than lifelong non-smokers. More-
over,cessationofcigarettesmokingatage60,50,40,or
30years,respectivelyaddedabout3,6,9,or10yearsof
life expectancy that they otherwise would have lost if
they continued to smoke.
19
Conclusions and policy implications
Previous studies in the UK
420 and US
21 showed that
abouthalfofthereductionincoronarydeathsbetween
1980 and 2000 could be attributable to reductions in
major risk factors and about half to improvements in
medical treatment of people with established vascular
disease. Our results provide support for the public
health policies aimed at achieving modest changes in
Table 4 |Hazard ratios for vascular and non-vascular mortality and life expectancy by cardiovascular risk factors at entry
when examined in combination
Risk factors* at baseline
Prevalence
atbaseline(%)
Vascular deaths Non-vascular deaths Mean (SE) life
expectancy
at age 50 Deaths HR† (95% CI) Deaths HR (95% CI)
Non-smokers
Low SBP, low cholesterol 17.0 701 1.0 955 1.0 33.3 (0.2)
Low SBP, high cholesterol 17.2 861 1.21 (1.09 to 1.33) 995 1.03 (0.94 to 1.12) 32.2 (0.2)
High SBP, low cholesterol 10.9 749 1.76 (1.58 to 1.95) 650 1.15 (1.04 to 1.27) 29.9 (0.3)
High SBP, high cholesterol 11.8 915 2.02 (1.83 to 2.23) 648 1.08 (0.97 to 1.19) 29.1 (0.3)
Smokers
Low SBP, low cholesterol 13.5 654 1.48 (1.33 to 1.65) 1086 1.86 (1.71 to 2.03) 28.1 (0.2)
Low SBP, high cholesterol 13.5 841 1.96 (1.77 to 2.16) 954 1.68 (1.53 to 1.83) 27.3 (0.3)
High SBP, low cholesterol 7.9 552 2.42 (2.16 to 2.71) 625 2.14 (1.93 to 2.37) 24.3 (0.4)
High SBP, high cholesterol 8.3 691 3.09 (2.78 to 3.44) 544 1.91 (1.72 to 2.12) 23.7 (0.4)
SBP=systolic blood pressure.
*“Low” blood pressure is <140 mm Hg, “low” cholesterol is baseline cholesterol <5.0 mmol/l.
†Hazard ratios adjusted for age at risk and calendar period.
Table 5 |Hazard ratios for vascular and non-vascular mortality and life expectancy by all cause mortality risk scores
Risk score categories
Prevalence
at baseline (%)
Vascular deaths Non-vascular deaths Life expectancy
at age 50 (SE) Deaths HR* (95% CI) Deaths HR (95% CI)
Risk score based on SBP, cholesterol, and smoking
1 (lowest fifth) 20.0 812 1.0 1044 1.0 33.5 (0.2)
2 20.0 1023 1.28 (1.17 to 1.41) 1240 1.23 (1.13 to 1.33) 31.2 (0.2)
3 20.0 1173 1.61 (1.47 to 1.76) 1336 1.47 (1.35 to 1.59) 29.4 (0.2)
4 20.0 1292 1.91 (1.75 to 2.09) 1387 1.66 (1.53 to 1.80) 27.6 (0.2)
5 (highest fifth) 20.0 1583 2.74 (2.51 to 2.98) 1353 1.94 (1.78 to 2.10) 24.2 (0.2)
Risk score based on SBP, cholesterol, smoking, BMI, grade, glucose intolerance, and diabetes
1 (lowest fifth) 20.0 782 1.0 977 1.0 34.0 (0.2)
2 20.0 1007 1.35 (1.23 to 1.49) 1223 1.34 (1.23 to 1.45) 31.3 (0.2)
3 20.0 1181 1.71 (1.56 to 1.87) 1260 1.50 (1.38 to 1.63) 29.8 (0.2)
4 20.0 1361 2.17 (1.98 to 2.37) 1390 1.86 (1.71 to 2.02) 26.9 (0.2)
5 (highest fifth) 20.0 1552 2.85 (2.60 to 3.11) 1510 2.41 (2.22 to 2.62) 23.6 (0.3)
Lowest 5% 5.0 154 1.0 228 1.0 35.4 (0.4)
Middle 90% 90.0 5276 2.18 (1.86 to 2.56) 5784 1.68 (1.47 to 1.92) 29.3 (0.1)
Highest 5% 5.0 453 4.65 (3.86 to 5.60) 348 2.70 (2.28 to 3.20) 20.2 (0.6)
SBP=systolic blood pressure, BMI=body mass index.
*Hazard ratios adjusted for age at risk and calendar period.
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achieve improvements in life expectancy.
22 We have
also shown that a greater proportion of older people
in the UK are surviving to very old age. Continued
public health strategies to lower mean levels of the
three main cardiovascular risk factors, together with
more intensive medical treatment for “high risk” sub-
groups, including use of medication to lower blood
pressure
2324 and cholesterol concentration,
25 that
have proved efficacy could result in further improve-
ments in life expectancy.
26
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WHAT IS ALREADY KNOWN ON THIS TOPIC
There has been uncertainty about the limits of life expectancy and the relevance of
cardiovascular risk factors for prediction of life expectancy
WHAT THIS STUDY ADDS
Despite substantial variability within individuals in levels of cardiovascular risk factors, the
presence of three major risk factors (smoking, high blood pressure, and high cholesterol
concentration) recorded on a single occasion in middle aged men was associated with a
10 year shorter life span from age 50 (23.7 v 33.3 years) compared men with none of them
More extreme categorisation of these risk factors including BMI, diabetes mellitus/glucose
intolerance, and employment grade was associated with a 15 year difference in life
expectancy from age 50 (20.2 v 35.4 years)
Continued public health strategies to lower these risk factors could result in further
improvements in life expectancy
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